Serum levels of angiogenic factors indicate a pro-angiogenic state in adults with sickle cell disease

被引:40
作者
Duits, AJ
Rodriguez, T
Schnog, JJB
机构
[1] Red Cross Blood Bank Fdn, Immunol Lab Dept, Curacao, Neth Antilles
[2] Slotervaartziekenhuis, Dept Internal Med, Amsterdam, Netherlands
关键词
sickle cell disease; angiogenesis; angiopoietins; vascular endothelial growth factor; tunica intima endothelial kinase 2;
D O I
10.1111/j.1365-2141.2006.06103.x
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Hypoxia-induced angiogenesis may play an important role in the pathophysiology of sickle cell disease (SCD). Serum levels of angiopoietin (Ang)-1, Ang-2, vascular endothelial growth factor, placenta growth factor (PlGF), soluble tunica intima endothelial kinase 2 (sTIE2), erythropoietin (EPO) and endothelial activation markers (soluble vascular adhesion molecule-1, soluble intercellular adhesion molecule-1) were determined in controls, HbSS (n = 35) and HbSC (n = 23) patients. In the asymptomatic phase, serum Ang-2 (P < 0.001), EPO (P < 0.001) and sTIE2 (P = 0.03) were elevated in patients. During painful crises, increased Ang-2 (P < 0.001) and PlGF (P = 0.04) occurred in HbSS and Ang-2 (P = 0.05) in HbSC patients. These results indicate a pro-angiogenic state in SCD, mainly because of elevated Ang-2 levels.
引用
收藏
页码:116 / 119
页数:4
相关论文
共 12 条
[1]
Duits AJ, 1998, EUR J HAEMATOL, V61, P302
[2]
Clinician guide to angiogenesis [J].
Fam, NP ;
Verma, S ;
Kutryk, M ;
Stewart, DJ .
CIRCULATION, 2003, 108 (21) :2613-2618
[3]
The Tie-2 ligand angiopoietin-2 is stored in and rapidly released upon stimulation from endothelial cell Weibel-Paladebodies [J].
Fiedler, U ;
Scharpfenecker, M ;
Koidl, S ;
Hegen, A ;
Grunow, V ;
Schmidt, JM ;
Kriz, W ;
Thurston, G ;
Augustin, HG .
BLOOD, 2004, 103 (11) :4150-4156
[4]
Platelets and VEGF blood levels in cancer patients [J].
Gunsilius, E ;
Gastl, G .
BRITISH JOURNAL OF CANCER, 1999, 81 (01) :185-186
[5]
Clinical relevance of vascular endothelial growth factor levels in sickle cell disease [J].
Gürkan, E ;
Tanriverdi, K ;
Baslamish, F .
ANNALS OF HEMATOLOGY, 2005, 84 (02) :71-75
[6]
The angiopoietin/Tie-2 system in proliferative sickle retinopathy: relation to vascular endothelial growth factor, its soluble receptor Flt-1 and von Willebrand factor, and to the effects of laser treatment [J].
Mohan, JS ;
Lip, PL ;
Blann, AD ;
Bareford, D ;
Lip, GYH .
BRITISH JOURNAL OF OPHTHALMOLOGY, 2005, 89 (07) :815-819
[7]
Hypoxia and vascular endothelial growth factor selectively up-regulate angiopoietin-2 in bovine microvascular endothelial cells [J].
Oh, H ;
Takagi, H ;
Suzuma, K ;
Otani, A ;
Matsumura, M ;
Honda, Y .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (22) :15732-15739
[8]
Placenta growth factor activates monocytes and correlates with sickle cell disease severity [J].
Perelman, N ;
Selvaraj, SK ;
Batra, S ;
Luck, LR ;
Erdreich-Epstein, A ;
Coates, TD ;
Kalra, VK ;
Malik, P .
BLOOD, 2003, 102 (04) :1506-1514
[9]
Sickle cell anemia as a possible state of enhanced anti-apoptotic tone: Survival effect of vascular endothelial growth factor on circulating and unanchored endothelial cells [J].
Solovey, A ;
Gui, LZ ;
Ramakrishnan, S ;
Steinberg, MH ;
Hebbel, RP .
BLOOD, 1999, 93 (11) :3824-3830
[10]
Sickle-cell disease [J].
Stuart, MJ ;
Nagel, RL .
LANCET, 2004, 364 (9442) :1343-1360